These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29129120)

  • 21. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
    Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D;
    J Viral Hepat; 2011 Jul; 18(7):e307-14. PubMed ID: 21692942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients.
    Carrasco I; Sainz T; Frick MA; Jiménez de Ory S; Fortuny C; Burgos J; Montero M; Gavilán C; Falcón MD; Couceiro JA; Bernardino JI; Bisbal O; Guerrero C; Aldámiz-Echevarría MT; Berenguer J; Navarro ML;
    J Viral Hepat; 2020 Sep; 27(9):955-958. PubMed ID: 32347645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens.
    Chen TY; Jain MK
    AIDS Patient Care STDS; 2015 Jun; 29(6):329-37. PubMed ID: 26020726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
    HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease.
    Rockstroh JK; Ingiliz P; Petersen J; Peck-Radosavljevic M; Welzel TM; Van der Valk M; Zhao Y; Jimenez-Exposito MJ; Zeuzem S
    Antivir Ther; 2017; 22(3):225-236. PubMed ID: 27845298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
    Luetkemeyer AF; McDonald C; Ramgopal M; Noviello S; Bhore R; Ackerman P
    Clin Infect Dis; 2016 Jun; 62(12):1489-96. PubMed ID: 27025835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.
    Sims OT; Womack BG
    Soc Work Public Health; 2015; 30(4):325-35. PubMed ID: 25811121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients.
    Braun DL; Rauch A; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Metzner KJ; Böni J; Weber R; Fehr J
    HIV Med; 2014 Nov; 15(10):625-30. PubMed ID: 24894776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs.
    Puoti M; Panzeri C; Rossotti R; Baiguera C
    Dig Liver Dis; 2014 Dec; 46 Suppl 5():S206-11. PubMed ID: 25458781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
    Marcellin F; Di Beo V; Aumaitre H; Mora M; Wittkop L; Duvivier C; Protopopescu C; Lacombe K; Esterle L; Berenger C; Gilbert C; Bouchaud O; Poizot-Martin I; Sogni P; Salmon-Ceron D; Carrieri P;
    J Hepatol; 2020 Mar; 72(3):588-591. PubMed ID: 31924411
    [No Abstract]   [Full Text] [Related]  

  • 32. Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
    Evon DM; Sarkar S; Amador J; Lok AS; Sterling RK; Stewart PW; Reeve BB; Serper M; Reau N; Reddy KR; Di Bisceglie AM; Nelson DR; Golin CE; Lim JK; Fried MW
    J Hepatol; 2020 Mar; 72(3):592-593. PubMed ID: 31889556
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV/HCV coinfection in Romania--can we afford not to treat?
    Sultana C; Erscoiu SM; Ceausu S; Ruta S
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):441-2. PubMed ID: 23256134
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients.
    Labarga P; Fernandez-Montero JV; de Mendoza C; Barreiro P; Pinilla J; Soriano V
    Antivir Ther; 2015; 20(3):329-34. PubMed ID: 25372299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
    Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
    Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
    Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
    J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
    Townsend K; Meissner EG; Sidharthan S; Sampson M; Remaley AT; Tang L; Kohli A; Osinusi A; Masur H; Kottilil S
    AIDS Res Hum Retroviruses; 2016 May; 32(5):456-62. PubMed ID: 26559180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does HIV Influence Hepatitis C Cure Rates Using Direct-Acting Antivirals?
    de Mendoza C
    AIDS Rev; 2016; 18(2):112-3. PubMed ID: 27232507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on HIV/HCV coinfection.
    Soriano V; Vispo E; Fernandez-Montero JV; Labarga P; Barreiro P
    Curr HIV/AIDS Rep; 2013 Sep; 10(3):226-34. PubMed ID: 23832718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals.
    Cope R; Pickering A; Glowa T; Faulds S; Veldkamp P; Prasad R
    AIDS Patient Care STDS; 2015 Jul; 29(7):379-83. PubMed ID: 26066094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.